Company intelligence / Profile preview

MEDIFOX DAN

Hildesheim, Niedersachsen (Lower Saxony), Germany

Ownership: Private
Employees: ~400
Development stage: Other

Overview

MEDIFOX DAN does not conduct drug or device clinical trials; its results are measured by adoption/market position, serving over 6,000 care institutions and supporting more than 300,000 caregivers in digitizing care and administrative operations across Germany. Its software is widely used for patient care documentation, billing, staffing plans, and (for mobile) outpatient services.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Previous investor Hgnow part of ResMed’s SaaS healthcare ecosystem

Beyond the preview

Go deeper on MEDIFOX DAN.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MEDIFOX DAN.

Explore the full profile